Image Place holder

Robert Weinfurtner, MD

Specialty: Radiology
Program: Diagnostic Imaging and Interventional Radiology

Call 1-888-MOFFITT
(1-888-663-3488)

Call 1-888-MOFFITT
(1-888-663-3488)


Locations: Moffitt McKinley Outpatient Center
Overview

Cancer Focus: Breast Cancer, Ductal Carcinoma In Situ , Inflammatory Breast Cancer , Invasive Ductal Carcinoma , Triple Negative Breast Cancer

Dr. Weinfurtner obtained his MD degree from Case Western Reserve University School of Medicine. He completed an internship at the University of Pennsylvania and a Radiology Residency at University Hospitals of Case Medical Center, where he served as Chief Resident. He most recently completed a Breast Imaging Fellowship at University of South Florida at Moffitt Cancer Center. Dr. Weinfurtner’s clinical interests involve multimodality diagnostic breast imagining. His research interest is in second opinion breast imaging and in breast cancer treatment response monitoring through imaging.

Education & Training

Board Certification:

  • Diagnostic Radiology

Fellowship:

  • Moffitt Cancer Center - Breast Imaging

Residency:

  • University Hospitals of Cleveland - Diagnostic Radiology

Medical School:

  • Case Western Reserve, University School of Medicine - MD
Participating Trials

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.

Publications

  • Soliman H, Hogue D, Han HS, Mooney B, Lima Barros Costa R, Lee MC, Niell B, Williams A, Chau A, Falcon S, Khakpour N, Weinfurtner RJ, Hoover S, Kiluk J, Rosa M, Khong H, Czerniecki BJ. A phase 1 trial of talimogene laherparepvec in combination with neoadjuvant chemotherapy for the treatment of non-metastatic triple-negative breast cancer. Clin Cancer Res. 2020 Nov. Pubmedid: 33219014.
  • Funaro K, Prather A, Niell B, Jared Weinfurtner R. Tissue marker migration after MRI-guided breast biopsy: Migration frequency and associated factors. Breast J. 2020 Mar.26(3):440-445. Pubmedid: 31448455.
  • Weinfurtner RJ, Mooney B, Forbus J. Specialized Second Opinion Review of Breast MRI Impacts Management and Increases Cancer Detection. J Am Coll Radiol. 2019 Jul.16(7):922-927. Pubmedid: 30833163.
  • Falcon S, Weinfurtner RJ, Mooney B, Niell BL. SAVI SCOUT® localization of breast lesions as a practical alternative to wires: Outcomes and suggestions for trouble-shooting. Clin Imaging. 2019 Jan.52:280-286. Pubmedid: 30193186.
  • Weinfurtner RJ, Niell B, Mekhail Y, Aguila E, Kamat L. Specialized Second Opinion Interpretations of Breast Imaging: Impact on Additional Workup and Management. Clin Breast Cancer. 2018 Oct.18(5):e1031-e1036. Pubmedid: 29625911.
  • Assing MA, Patel BK, Karamsadkar N, Weinfurtner J, Usmani O, Kiluk JV, Drukteinis JS. A comparison of the diagnostic accuracy of magnetic resonance imaging to axillary ultrasound in the detection of axillary nodal metastases in newly diagnosed breast cancer. Breast J. 2017 Nov.23(6):647-655. Pubmedid: 28397344.
  • Niell BL, Freer PE, Weinfurtner RJ, Arleo EK, Drukteinis JS. Screening for Breast Cancer. Radiol Clin North Am. 2017 Nov.55(6):1145-1162. Pubmedid: 28991557.
  • Pribish AM, Saglam O, Weinfurtner RJ. Estrogen receptor-positive primary squamous cell carcinoma of the breast. Radiol Case Rep. 2017 Jun.12(2):211-214. Pubmedid: 28491153. Pmcid: PMC5417723.
  • Falcon S, Williams A, Weinfurtner J, Drukteinis JS. Imaging Management of Breast Density, a Controversial Risk Factor for Breast Cancer. Cancer Control. 2017 Apr.24(2):125-136. Pubmedid: 28441367.
  • Kamat L, Rosa M, Weinfurtner R, Drukteinis J, Falcon S, Patel B. Primary Breast Angiosarcoma in a Male. Breast J. 2016 Jun.21(5):545-548. Pubmedid: 26183811.
  • Chaudhury B, Zhou M, Goldgof DB, Hall LO, Gatenby RA, Gillies RJ, Patel BK, Weinfurtner RJ, Drukteinis JS. Heterogeneity in intratumoral regions with rapid gadolinium washout correlates with estrogen receptor status and nodal metastasis. J Magn Reson Imaging. 2015 Nov.42(5):1421-1430. Pubmedid: 25884277. Pmcid: PMC5017794.
  • Weinfurtner RJ, Patel B, Laronga C, Lee MC, Falcon SL, Mooney BP, Yue B, Drukteinis JS. Magnetic resonance imaging-guided core needle breast biopsies resulting in high-risk histopathologic findings: upstage frequency and lesion characteristics. Clin Breast Cancer. 2015 Jun.15(3):234-239. Pubmedid: 25579460.

Patient Comments
Overall Satisfaction
0

0 patients rated this provider

The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.

Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Learn more about our patient satisfaction survey

Comments ()

Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.

We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.

Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.

Learn more about our patient comments

Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:

  • The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 30 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
  • He or she may be a researcher or other type of provider that does not see patients.
  • The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.
Learn more about our patient satisfaction survey, ratings and comments